Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2413)
All Articles published online
|
Nov 14, 2005 (publication date) through Apr 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chang WW, Su IJ, Lai MD, Chang WT, Huang W, Lei HY. Toll-like receptor 4 plays an anti-HBV role in a murine model of acute hepatitis B virus expression. World J Gastroenterol 2005; 11(42): 6631-6637 [PMID: 16425356 DOI: 10.3748/wjg.v11.i42.6631] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i42/6631.htm |
| Number | Citing Articles |
| 1 |
Yasuteru Kondo, Yoshiyuki Ueno, Tooru Shimosegawa. Toll-Like Receptors Signaling Contributes to Immunopathogenesis of HBV Infection. Gastroenterology Research and Practice 2011; 2011: 1 doi: 10.1155/2011/810939
|
| 2 |
Zhi-Feng Wu, Xiao-Hui Zhou, Yun-Wen Hu, Le-Yuan Zhou, Ya-Bo Gao, Xiu-Hua Peng, Xiao-Hua Yang, Jian-Ying Zhang, Yong Hu, Zhao-Chong Zeng. TLR4-dependant immune response, but not hepatitis B virus reactivation, is important in radiation-induced liver disease of liver cancer radiotherapy. Cancer Immunology, Immunotherapy 2014; 63(3): 235 doi: 10.1007/s00262-013-1504-9
|
| 3 |
Kent Doi, Tomoko Ishizu, Maki Tsukamoto-Sumida, Takahiro Hiruma, Tetsushi Yamashita, Emi Ogasawara, Yoshifumi Hamasaki, Naoki Yahagi, Masaomi Nangaku, Eisei Noiri. The high-mobility group protein B1–Toll-like receptor 4 pathway contributes to the acute lung injury induced by bilateral nephrectomy. Kidney International 2014; 86(2): 316 doi: 10.1038/ki.2014.62
|
| 4 |
Bing-Yi Zhang, Dan-Ping Chai, Yi-Hang Wu, Li-Peng Qiu, Yong-Yong Zhang, Zi-Hong Ye, Xiao-Ping Yu. Potential Drug Targets Against Hepatitis B Virus Based on Both Virus and Host Factors. Current Drug Targets 2019; 20(16): 1636 doi: 10.2174/1389450120666190729115646
|
| 5 |
Mohammad Zare-Bidaki, Kyoko Tsukiyama-Kohara, Mohammad Kazemi Arababadi. Toll-Like Receptor 4 and Hepatitis B Infection: Molecular Mechanisms and Pathogenesis. Viral Immunology 2014; 27(7): 321 doi: 10.1089/vim.2014.0039
|
| 6 |
Raymund R. Razonable, Albert Eid, Martin Henault. Antiviral Research. 2014; : 333 doi: 10.1128/9781555815493.ch19
|
| 7 |
Xiu-Hua Peng, Xiao-Nan Ren, Li-Xiang Chen, Bi-Sheng Shi, Chun-Hua Xu, Zhong Fang, Xue Liu, Jie-Liang Chen, Xiao-Nan Zhang, Yun-Wen Hu, Xiao-Hui Zhou. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice. World Journal of Gastroenterology 2015; 21(12): 3527-3536 doi: 10.3748/wjg.v21.i12.3527
|
| 8 |
Xiaoyong Zhang, Anke Kraft, Ruth Broering, Joerg F Schlaak, Ulf Dittmer, Mengji Lu. Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections. Expert Opinion on Drug Discovery 2012; 7(7): 597 doi: 10.1517/17460441.2012.689281
|
| 9 |
|
| 10 |
Rohit Sawhney, Kumar Visvanathan. Polymorphisms of Toll-Like Receptors and Their Pathways in Viral Hepatitis. Antiviral Therapy 2011; 16(4): 443 doi: 10.3851/IMP1820
|
| 11 |
Darren J. Wong, Stephen A. Locarnini, Alexander J.V. Thompson. Clinical Virology. 2016; : 713 doi: 10.1128/9781555819439.ch32
|